|
Clinical Intervention: Definitive (Phase III) Clinical or Translational Trials
Contributing journals to this collection:
Cancer Prevention Journals Portal,
Cancer Prevention Journals Portal Content,
,
Cancer Reviews Online,
Molecular Cancer Research,
Cancer Prevention Research,
Molecular Cancer Therapeutics,
Cancer Research,
Cancer Reviews Online Content,
Clinical Cancer Research,
and Cancer Epidemiology Biomarkers & Prevention
Citations 1-7 of 7 total displayed.
- Null Results in Brief
IGF-I, IGFBP-3, and IGF-I/IGFBP-3 Ratio: No Association with Incident Colorectal Cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
- Joshua B. Max, Paul J. Limburg, Adeboye Ogunseitan, Rachael Z. Stolzenberg-Solomon, Robert A. Vierkant, Michael J. Pollak, Thomas A. Sellers, Jarmo Virtamo, James R. Cerhan, and Demetrius Albanes
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1832-1834.
[Full text]
[PDF]
- Research Article
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
- Frank L. Meyskens, Jr., Christine E. McLaren, Daniel Pelot, Sharon Fujikawa-Brooks, Philip M. Carpenter, Ernest Hawk, Gary Kelloff, Michael J. Lawson, Jayashri Kidao, John McCracken, C. Gregory Albers, Dennis J. Ahnen, D. Kim Turgeon, Steven Goldschmid, Peter Lance, Curt H. Hagedorn, Daniel L. Gillen, and Eugene W. Gerner
Cancer Prevention Research first published on Apr 14, 2008 as doi: 10.1158/1940-6207.CAPR-08-0042.
[Abstract]
Online First [PDF]
[ Perspective on This Article ]
- Research Article
Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial
- Nancy L. Cho, Mark Redston, Ann G. Zauber, Adelaide M. Carothers, Jason Hornick, Andrew Wilton, Stephen Sontag, Norman Nishioka, Francis M. Giardiello, John R. Saltzman, Chris Gostout, Craig J. Eagle, Ernest T. Hawk, and Monica M. Bertagnolli
Cancer Prevention Research first published on Apr 14, 2008 as doi: 10.1158/1940-6207.CAPR-07-0011.
[Abstract]
Online First [PDF]
[ Perspective on This Article ]
- Cancer Therapy: Clinical
Phase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder Cancer
- Anita L. Sabichi, Seth P. Lerner, E. Neely Atkinson, H. Barton Grossman, Nancy P. Caraway, Colin P. Dinney, David F. Penson, Surena Matin, Ashish Kamat, Louis L. Pisters, Daniel W. Lin, Ruth L. Katz, Dean E. Brenner, George P. Hemstreet, III, Mary Wargo, Archie Bleyer, William H. Sanders, John L. Clifford, Howard L. Parnes, and Scott M. Lippman
Clin. Cancer Res. 2008; 14: 224-229.
[Abstract]
[Full text]
[PDF]
- Research Articles
The Polyp Prevention Trial–Continued Follow-up Study: No Effect of a Low-Fat, High-Fiber, High-Fruit, and -Vegetable Diet on Adenoma Recurrence Eight Years after Randomization
- Elaine Lanza, Binbing Yu, Gwen Murphy, Paul S. Albert, Bette Caan, James R. Marshall, Peter Lance, Electra D. Paskett, Joel Weissfeld, Marty Slattery, Randall Burt, Frank Iber, Moshe Shike, James W. Kikendall, Brenda K. Brewer, Arthur Schatzkin the Polyp Prevention Trial Study Group
Cancer Epidemiol. Biomarkers Prev. 2007; 16: 1745-1752.
[Abstract]
[Full text]
[PDF]
- Research Articles
Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia
- James R. Marshall, Wael Sakr, David Wood, Donna Berry, Catherine Tangen, Felicia Parker, Ian Thompson, Scott M. Lippman, Ronald Lieberman, David Alberts, David Jarrard, Charles Coltman, Peter Greenwald, Lori Minasian, and E. David Crawford
Cancer Epidemiol. Biomarkers Prev. 2006; 15: 1479-1484.
[Abstract]
[Full text]
[PDF]
- Null Results in Brief
Lung Cancer Chemoprevention: A Randomized, Double-Blind Trial in Linxian, China
- Farin Kamangar, You-Lin Qiao, Binbing Yu, Xiu-Di Sun, Christian C. Abnet, Jin-Hu Fan, Steven D. Mark, Ping Zhao, Sanford M. Dawsey, and Philip R. Taylor
Cancer Epidemiol. Biomarkers Prev. 2006; 15: 1562-1564.
[Abstract]
[Full text]
[PDF]
|
|
Collected Resources Home
|
|
|
|